242 related articles for article (PubMed ID: 26177433)
21. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
22. Localized non-conventional renal cell carcinoma: prediction of clinical outcome according to histology.
Kim SH; Yang HK; Moon KC; Lee ES
Int J Urol; 2014 Apr; 21(4):359-64. PubMed ID: 24224568
[TBL] [Abstract][Full Text] [Related]
23. Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
Brookman-May S; May M; Zigeuner R; Shariat SF; Scherr DS; Chromecki T; Moch H; Wild PJ; Mohamad-Al-Ali B; Cindolo L; Wieland WF; Schips L; De Cobelli O; Rocco B; Santoro L; De Nunzio C; Tubaro A; Coman I; Feciche B; Truss M; Dalpiaz O; Hohenfellner M; Gilfrich C; Wirth MP; Burger M; Pahernik S;
J Urol; 2011 Dec; 186(6):2175-81. PubMed ID: 22014800
[TBL] [Abstract][Full Text] [Related]
24. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
25. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
26. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.
Delahunt B; Bethwaite PB; Nacey JN
Pathology; 2007 Oct; 39(5):459-65. PubMed ID: 17886093
[TBL] [Abstract][Full Text] [Related]
27. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
[TBL] [Abstract][Full Text] [Related]
28. Grading of renal cell carcinoma.
Delahunt B; Eble JN; Egevad L; Samaratunga H
Histopathology; 2019 Jan; 74(1):4-17. PubMed ID: 30565310
[TBL] [Abstract][Full Text] [Related]
29. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
30. Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases.
Perrino CM; Grignon DJ; Williamson SR; Idrees MT; Eble JN; Cheng L
Histopathology; 2018 Jan; 72(2):305-319. PubMed ID: 28833389
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.
Patard JJ; Leray E; Rioux-Leclercq N; Cindolo L; Ficarra V; Zisman A; De La Taille A; Tostain J; Artibani W; Abbou CC; Lobel B; Guillé F; Chopin DK; Mulders PF; Wood CG; Swanson DA; Figlin RA; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2005 Apr; 23(12):2763-71. PubMed ID: 15837991
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Hoefler G; Pummer K; Zigeuner R
Histopathology; 2013 Jan; 62(2):237-46. PubMed ID: 23020176
[TBL] [Abstract][Full Text] [Related]
33. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up.
Przybycin CG; McKenney JK; Reynolds JP; Campbell S; Zhou M; Karafa MT; Magi-Galluzzi C
Am J Surg Pathol; 2014 Sep; 38(9):1260-5. PubMed ID: 25127094
[TBL] [Abstract][Full Text] [Related]
34. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
[TBL] [Abstract][Full Text] [Related]
35. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
36. [Clinical pathological features of small renal cell cancer: a single-center experience on 1 267 cases].
Yang KW; Zhang CJ; Li XS; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):790-3. PubMed ID: 25331406
[TBL] [Abstract][Full Text] [Related]
37. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma.
Chapman-Fredricks JR; Herrera L; Bracho J; Gomez-Fernandez C; Leveillee R; Rey L; Jorda M
Ann Diagn Pathol; 2011 Oct; 15(5):333-7. PubMed ID: 21665507
[TBL] [Abstract][Full Text] [Related]
38. Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified.
Bhatt JR; Jewett MA; Richard PO; Kawaguchi S; Timilshina N; Evans A; Alibhai S; Finelli A
J Urol; 2016 Nov; 196(5):1350-1355. PubMed ID: 27341751
[TBL] [Abstract][Full Text] [Related]
39. Histopathological characteristics of adult renal tumours: a preliminary report.
Latif F; Mubarak M; Kazi JI
J Pak Med Assoc; 2011 Mar; 61(3):224-8. PubMed ID: 21465932
[TBL] [Abstract][Full Text] [Related]
40. [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].
Moch H
Pathologe; 2016 Mar; 37(2):127-33. PubMed ID: 26942728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
